Barriers to the use of three-month paliperidone palmitate formulation: a study from an Italian real-world setting.

Giovanna Cirnigliaro,Vera Battini,Rita Cafaro,Giulia Mosini,Simone Vanzetto, Tiziano Prodi,Monica Macellaro,Rodolfo Leuzzi,Dario Conti,Carla Carnovale,Bernardo Dell'osso

Expert review of neurotherapeutics（2023）

引用 0|浏览4

暂无评分

摘要

PP3M initiation was associated with an overall HRU reduction. Subjects switched to PP3M had similar HRU when compared with those who did not, suggesting similar clinical conditions in both groups.

查看译文

关键词

Paliperidone palmitate 3-month formulation, schizophrenia, health resource use, hospitalizations, barriers

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要